BSX Boston Scientific Corp.
As of 11:18:00 AM ET
Loading chart…
- Open
- $42.10
- Previous close
- $41.98
- Day range
- 41.94 – 43.61
- 52-week range
- 39.57 – 105.65
- Volume
- 589.3K
- Avg volume (3M)
- 19.6M
- Market cap
- $60.8B
- P/E (TTM)
- 18.01
- EPS (TTM)
- $2.37
- Beta
- —
- Dividend yield
- 0.00%
- Next earnings
- Feb 3, 2027(estimated from past report dates; not yet confirmed by the company)
- Ex-dividend
- —
- Sector
- Healthcare
About Boston Scientific Corp.
Boston Scientific Corp. is a medical device company focused on developing, manufacturing, and marketing technologies used in interventional medical procedures worldwide. The company’s portfolio serves a broad range of clinical areas, including cardiology, peripheral interventions, endoscopy, urology, and neuromodulation. Its MedSurg segment covers products for digestive health, urinary care, and pain management, while its Cardiovascular segment supports minimally invasive treatment options for heart and vascular conditions. Boston Scientific’s devices are designed to help healthcare professionals diagnose and treat patients through less invasive approaches across hospitals, clinics, and specialized medical centers. Headquartered in Marlborough, Massachusetts, Boston Scientific plays a significant role in the global health care equipment market through its broad mix of procedure-based products and physician-focused solutions.
Next report: Wed, Feb 3, 2027(estimated from past report dates; not yet confirmed by the company)
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Oct 28, 2026(after close) | $0.72 | $0.73 | +1.4% |
| Jul 29, 2026(after close) | $0.83 | $0.86 | +3.6% |
| Apr 22, 2026(after close) | $0.79 | $0.80 | +1.3% |
| Feb 4, 2026(after close) | $0.78 | $0.80 | +2.6% |
| Oct 22, 2025(after close) | $0.71 | $0.75 | +5.6% |
| Oct 8, 2025(after close) | $0.04 | $0.04 | 0.0% |
BSX doesn’t pay a dividend.
BSX news and filings
Loading filings…
Filings from SEC EDGAR.